New patient-centric AI-based approach accelerates access to new therapies
Long timelines and high costs per patient burden clinical trials, delaying effective treatments for the patients who need them most. But now, an AI-based approach called a TwinRCT™ has proven it can successfully overcome these challenges by reducing control arm sizes by more than 30% while generating reliable evidence in a fraction of the time. Learn more.
DOJ wields a long-overlooked tool to protect people with addiction; the gender gap in scientific authorship
Reviewed by Knowledge World
on
June 22, 2022
Rating: 5
No comments